These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of acute physical exercise on cytokine levels in patients with systemic lupus erythematosus. da Silva AE; dos Reis-Neto ET; da Silva NP; Sato EI Lupus; 2013 Dec; 22(14):1479-83. PubMed ID: 24135080 [TBL] [Abstract][Full Text] [Related]
4. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus. Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810 [TBL] [Abstract][Full Text] [Related]
7. A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus. Bortoluzzi A; Vincenzi F; Govoni M; Padovan M; Ravani A; Borea PA; Varani K Arthritis Res Ther; 2016 Aug; 18(1):192. PubMed ID: 27566294 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokine kinetics to single bouts of acute moderate and intense aerobic exercise in women with active and inactive systemic lupus erythematosus. Perandini LA; Sales-de-Oliveira D; Mello S; Camara NO; Benatti FB; Lima FR; Borba E; Bonfa E; Roschel H; Sá-Pinto AL; Gualano B Exerc Immunol Rev; 2015; 21():174-85. PubMed ID: 25825870 [TBL] [Abstract][Full Text] [Related]
9. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment. López P; Gómez J; Prado C; Gutiérrez C; Suárez A J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405 [TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus. Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926 [TBL] [Abstract][Full Text] [Related]
11. Abnormal in vitro CXCR2 modulation and defective cationic ion transporter expression on polymorphonuclear neutrophils responsible for hyporesponsiveness to IL-8 stimulation in patients with active systemic lupus erythematosus. Hsieh SC; Wu TH; Tsai CY; Li KJ; Lu MC; Wu CH; Yu CL Rheumatology (Oxford); 2008 Feb; 47(2):150-7. PubMed ID: 18208820 [TBL] [Abstract][Full Text] [Related]
12. Exercise training can attenuate the inflammatory milieu in women with systemic lupus erythematosus. Perandini LA; Sales-de-Oliveira D; Mello SB; Camara NO; Benatti FB; Lima FR; Borba E; Bonfa E; Sá-Pinto AL; Roschel H; Gualano B J Appl Physiol (1985); 2014 Sep; 117(6):639-47. PubMed ID: 25038103 [TBL] [Abstract][Full Text] [Related]
13. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels. Liou LB Clin Exp Rheumatol; 2003; 21(4):437-44. PubMed ID: 12942694 [TBL] [Abstract][Full Text] [Related]
14. Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage. Huang W; Wu J; Yang H; Xiong Y; Jiang R; Cui T; Ye D Cell Death Differ; 2017 Feb; 24(2):263-275. PubMed ID: 27768123 [TBL] [Abstract][Full Text] [Related]
15. Phagocyte activity in the peripheral blood of pregnant women with systemic lupus erythematosus and in the cord blood of their newborns. Sukhikh GT; Safronova VG; Vanko LV; Matveeva NK; Belyaeva AS; Fedorova EV; Nikolaeva MA; Klimenchenko NI; Krechetova LV Int J Rheum Dis; 2017 May; 20(5):597-608. PubMed ID: 28464513 [TBL] [Abstract][Full Text] [Related]
16. Hyporesponsiveness to gammac-chain cytokines in activated lymphocytes from patients with systemic lupus erythematosus leads to accelerated apoptosis. Lorenz HM; Grünke M; Hieronymus T; Winkler S; Blank N; Rascu A; Wendler J; Geiler T; Kalden JR Eur J Immunol; 2002 May; 32(5):1253-63. PubMed ID: 11981812 [TBL] [Abstract][Full Text] [Related]
17. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. Chun HY; Chung JW; Kim HA; Yun JM; Jeon JY; Ye YM; Kim SH; Park HS; Suh CH J Clin Immunol; 2007 Sep; 27(5):461-6. PubMed ID: 17587156 [TBL] [Abstract][Full Text] [Related]
18. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients. McCarthy EM; Smith S; Lee RZ; Cunnane G; Doran MF; Donnelly S; Howard D; O'Connell P; Kearns G; Ní Gabhann J; Jefferies CA Rheumatology (Oxford); 2014 Sep; 53(9):1586-94. PubMed ID: 24706988 [TBL] [Abstract][Full Text] [Related]
19. [Comparative characteristics of immunological tests in differentiation of systemic and cutaneous forms of lupus erythematosus]. Romanova NV; Shilkina NP Ter Arkh; 2009; 81(4):40-3. PubMed ID: 19514420 [TBL] [Abstract][Full Text] [Related]
20. Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. Linker-Israeli M; Bakke AC; Quismorio FP; Horwitz DA J Clin Invest; 1985 Feb; 75(2):762-8. PubMed ID: 3156152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]